Jessica Skarzynski

These weekly recipes, created by oncology dieticians from the John Theurer Cancer Center, offer benefits to those living with cancer and going through treatment.

Here are the top 5 CURE stories for June 2019.

The growing use of telecommunication and technology to provide health care – or telemedicine – offers many advantages, but also comes with challenges, says one expert.

The president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association discussed new initiatives and what’s on the horizon in the treatment of liver cancer.

The growing use of immunotherapy in oncology has confronted many community practice-based oncologists with challenges to implementation, but one advocacy group’s new initiative aims to educate and empower.

Information about myeloproliferative neoplasms – or MPNs – is hard to come by. But the MPN Research Foundation’s myMPN Patient Registry aims to change that. Learn more about it in this week's episode of the CURE Talks Cancer podcast.

Jennifer King, from the GO2 Foundation for Lung Cancer, discussed what patients can do to help address the stigma associated with lung cancer.

Genomic testing has transformed the therapeutic landscape of lung cancer in recent years, but there is still room for improvement, says one expert.

Here are the top 5 CURE stories for May 2019.

Two oncology dietitians weigh in on the results of a recent study that show a low-fat diet rich in fruits, vegetables and grains can reduce the risk of dying from breast cancer.

Thousands of men who will be diagnosed with prostate cancer this year alone now have a wealth of new and updated resources to ensure they make the best treatment choices they can.

Here are the top 5 CURE stories for April 2019.

A new analysis of the myMPN Patient Registry has led to some exciting new discoveries, according to researchers.

After more than 30 years of relative stability, the treatment landscape for urothelial cancer has seen updates in recent years that provide hope for patients.

In this Special Edition of CURE Talks Cancer, we chat with Poison drummer and throat cancer survivor Rikki Rockett about his cancer journey and why it's important to "Open Up and Say... Ahh!" during Oral, Head and Neck Cancer Awareness Week.

An expert discusses how CAR-T cells will fit into the treatment paradigm for patients with multiple myeloma in the future.

Here are the top 5 CURE stories for March 2019.

This week, we spoke with all three of CURE’s 2019 Ovarian Cancer Heroes: Ryan Mitstifer Walton, Paula Anastasia, RN, MN, AOCN, and Shannon Westin, M.D., M.P.H.

In this week’s episode, we spoke with the most decorated Olympic gymnast and ovarian cancer survivor Shannon Miller before CURE’s second annual Ovarian Cancer Heroes gala.

The importance of teamwork between patients and their caregivers was a common theme at the second annual Ovarian Cancer Heroes event held in Honolulu, Hawaii.

Women with frequent urinary tract infections (UTIs) were more likely to experience lower quality diagnostic processes when it comes to screening for bladder and kidney cancer.

Here are the top 5 CURE stories for February 2019.

In patients with mantle cell lymphoma, the introduction of BTK inhibitors continues to shape the treatment landscape.

One expert weighs in on the use of new immunotherapy agents and combinations in treating non-small cell lung cancer.

Here are the top 5 CURE stories for January 2019.

While some high-risk patients with mantle cell lymphoma may benefit from aggressive initial therapy, a recent study found that this may not be necessary for others who could benefit from more targeted therapies.

The addition of the investigational drug alisertib to a paclitaxel regimen showed promising activity in patients with recurrent ovarian cancer or advanced breast cancer.

A recent meta-analysis has found no noticeable difference in immunotherapy’s efficacy based on patient sex.

Cancer survivorship is an important topic that patients and physicians must consider when planning their treatment.

For young breast cancer survivors, the type of surgery they recieve to treat their disease can impact their quality of life, according to recent research.